Three studies in type 2 diabetes: ADOPT Rosiglitazone monotherapy in type 2 diabetes: what indication?

被引：0
|
作者：
Roussel, R. [1 ]
机构：
[1] CHU Bichat Claude Bernard, Serv Endocrinol Diabetol Nutr, F-75722 Paris 18, France
来源：
ANNALES D ENDOCRINOLOGIE | 2007年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S28 / S32
页数：5
相关论文
共 50 条
  • [41] Costs and effectiveness of insulin vs. rosiglitazone in type 2 diabetes after metformin monotherapy failure
    Skoupa, J.
    Cerna, V
    Rausova, V
    Pavlikova, P.
    VALUE IN HEALTH, 2008, 11 (03) : A225 - A225
  • [42] Metformin monotherapy for adults with type 2 diabetes mellitus
    Gnesin, Filip
    Thuesen, Anne Cathrine Baun
    Kahler, Lise Katrine Aronsen
    Madsbad, Sten
    Hemmingsen, Bianca
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [43] Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes
    Van Wijk, JPH
    Cabezas, MC
    Coll, B
    Joven, J
    Rabelink, TJ
    de Koning, EJP
    ATHEROSCLEROSIS, 2006, 186 (01) : 152 - 159
  • [44] Rosiglitazone reduces platelet aggregation in type 2 diabetes mellitus
    Pacheco, GS
    Miller, L
    Davis-Gorman, G
    McDonagh, P
    FASEB JOURNAL, 2006, 20 (04): : A297 - A298
  • [45] Trials that matter: Rosiglitazone, ramipril, and the prevention of type 2 diabetes
    Nathan, David M.
    Berkwits, Michael
    ANNALS OF INTERNAL MEDICINE, 2007, 146 (06) : 461 - 463
  • [46] Rosiglitazone - A review of its use in type 2 diabetes mellitus
    Deeks, Emma D.
    Keam, Susan J.
    DRUGS, 2007, 67 (18) : 2747 - 2779
  • [47] Rosiglitazone improves quality of lipoproteins in patients with type 2 diabetes
    Vrablik, M.
    Dobiasova, M.
    Stulc, T.
    Kasalova, Z.
    Ceska, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 371 - 371
  • [48] Rosiglitazone in the management of older patients with type 2 diabetes mellitus
    Kreider, M
    Heise, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (07) : 538 - 541
  • [49] Endotoxemia in type 2 diabetes is related to hyperinsulinemia and is reduced by rosiglitazone
    Creely, SJ
    McTernan, PG
    Harte, AL
    Farmer, J
    Khanolkar, M
    Evans, M
    Kumar, S
    DIABETES, 2005, 54 : A326 - A326
  • [50] Rosiglitazone plus metformin to prevent type 2 diabetes mellitus
    Malaga, German
    Miranda, Juan J.
    LANCET, 2010, 376 (9750): : 1387 - 1387
12345